MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

OraSure Technologies Inc

Затворен

СекторЗдравеопазване

3.02 -0.33

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

3

Максимум

3.1

Ключови измерители

By Trading Economics

Приходи

32M

16M

Продажби

-903K

31K

Марж на печалбата

51,226.768

Служители

501

EBITDA

3.9M

-14M

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-13M

220M

Предишно отваряне

3.35

Предишно затваряне

3.02

Настроения в новините

By Acuity

50%

50%

159 / 371 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

OraSure Technologies Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

17.10.2025 г., 18:13 ч. UTC

Значими двигатели на пазара

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17.10.2025 г., 17:05 ч. UTC

Значими двигатели на пазара

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

17.10.2025 г., 15:03 ч. UTC

Значими двигатели на пазара

Obook Shares Sink Following Public Debut

17.10.2025 г., 14:41 ч. UTC

Значими двигатели на пазара

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

17.10.2025 г., 23:25 ч. UTC

Придобивния, сливания и поглъщания

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17.10.2025 г., 22:15 ч. UTC

Пазарно говорене

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17.10.2025 г., 21:15 ч. UTC

Пазарно говорене

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17.10.2025 г., 21:07 ч. UTC

Пазарно говорене

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17.10.2025 г., 21:07 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

17.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.10.2025 г., 20:34 ч. UTC

Пазарно говорене

Deere Is Reaching the End of Its Downcycle -- Market Talk

17.10.2025 г., 20:27 ч. UTC

Пазарно говорене

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17.10.2025 г., 19:46 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17.10.2025 г., 19:45 ч. UTC

Пазарно говорене

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17.10.2025 г., 18:45 ч. UTC

Пазарно говорене

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17.10.2025 г., 17:51 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.10.2025 г., 17:51 ч. UTC

Пазарно говорене

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17.10.2025 г., 17:44 ч. UTC

Пазарно говорене

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17.10.2025 г., 17:35 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17.10.2025 г., 16:20 ч. UTC

Пазарно говорене
Печалби

Tech, Media & Telecom Roundup: Market Talk

17.10.2025 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.10.2025 г., 16:14 ч. UTC

Пазарно говорене

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17.10.2025 г., 16:04 ч. UTC

Пазарно говорене

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17.10.2025 г., 15:58 ч. UTC

Пазарно говорене

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17.10.2025 г., 15:56 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17.10.2025 г., 15:43 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

17.10.2025 г., 15:43 ч. UTC

Пазарно говорене

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

17.10.2025 г., 14:58 ч. UTC

Пазарно говорене

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

17.10.2025 г., 14:41 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.10.2025 г., 14:35 ч. UTC

Пазарно говорене
Печалби

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

OraSure Technologies Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

0

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

N/A / 2.975Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

Weak Bearish Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

159 / 371 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно OraSure Technologies Inc

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
help-icon Live chat